Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in Abdominal Sepsis
NCT00357123Phase 2Unknown
- Sponsor
- Universidad Autónoma de San Luis Potosí
- Start
- Aug 2006
- Primary completion
- Jul 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of rosuvastatin in abdominal sepsis (2 arms), sponsored by Universidad Autónoma de San Luis Potosí. Primary endpoint: Plasmatic levels of Interleukine 6, 1B, and Tumor Necrosis Factor alpha at Day 3. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
abdominal sepsis
Beyond the preview
Go deeper on NCT00357123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357123.